Form 8-K - Current report:
SEC Accession No. 0001104659-25-002862
Filing Date
2025-01-13
Accepted
2025-01-13 07:50:28
Documents
55
Period of Report
2025-01-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm252956d1_8k.htm   iXBRL 8-K 26470
2 EXHIBIT 99.1 tm252956d1_ex99-1.htm EX-99.1 69888
6 GRAPHIC tm252956d1_ex99-1img001.jpg GRAPHIC 178774
7 GRAPHIC tm252956d1_ex99-1img002.jpg GRAPHIC 248569
8 GRAPHIC tm252956d1_ex99-1img003.jpg GRAPHIC 192094
9 GRAPHIC tm252956d1_ex99-1img004.jpg GRAPHIC 149078
10 GRAPHIC tm252956d1_ex99-1img005.jpg GRAPHIC 202606
11 GRAPHIC tm252956d1_ex99-1img006.jpg GRAPHIC 116473
12 GRAPHIC tm252956d1_ex99-1img007.jpg GRAPHIC 175494
13 GRAPHIC tm252956d1_ex99-1img008.jpg GRAPHIC 142017
14 GRAPHIC tm252956d1_ex99-1img009.jpg GRAPHIC 174385
15 GRAPHIC tm252956d1_ex99-1img010.jpg GRAPHIC 40566
16 GRAPHIC tm252956d1_ex99-1img011.jpg GRAPHIC 160677
17 GRAPHIC tm252956d1_ex99-1img012.jpg GRAPHIC 49306
18 GRAPHIC tm252956d1_ex99-1img013.jpg GRAPHIC 203144
19 GRAPHIC tm252956d1_ex99-1img014.jpg GRAPHIC 141707
20 GRAPHIC tm252956d1_ex99-1img015.jpg GRAPHIC 134893
21 GRAPHIC tm252956d1_ex99-1img016.jpg GRAPHIC 118977
22 GRAPHIC tm252956d1_ex99-1img017.jpg GRAPHIC 156135
23 GRAPHIC tm252956d1_ex99-1img018.jpg GRAPHIC 43353
24 GRAPHIC tm252956d1_ex99-1img019.jpg GRAPHIC 152277
25 GRAPHIC tm252956d1_ex99-1img020.jpg GRAPHIC 166671
26 GRAPHIC tm252956d1_ex99-1img021.jpg GRAPHIC 181883
27 GRAPHIC tm252956d1_ex99-1img022.jpg GRAPHIC 43373
28 GRAPHIC tm252956d1_ex99-1img023.jpg GRAPHIC 157819
29 GRAPHIC tm252956d1_ex99-1img024.jpg GRAPHIC 189394
30 GRAPHIC tm252956d1_ex99-1img025.jpg GRAPHIC 152566
31 GRAPHIC tm252956d1_ex99-1img026.jpg GRAPHIC 41798
32 GRAPHIC tm252956d1_ex99-1img027.jpg GRAPHIC 130544
33 GRAPHIC tm252956d1_ex99-1img028.jpg GRAPHIC 156402
34 GRAPHIC tm252956d1_ex99-1img029.jpg GRAPHIC 174684
35 GRAPHIC tm252956d1_ex99-1img030.jpg GRAPHIC 162240
36 GRAPHIC tm252956d1_ex99-1img031.jpg GRAPHIC 154855
37 GRAPHIC tm252956d1_ex99-1img032.jpg GRAPHIC 146031
38 GRAPHIC tm252956d1_ex99-1img033.jpg GRAPHIC 158065
39 GRAPHIC tm252956d1_ex99-1img034.jpg GRAPHIC 204020
40 GRAPHIC tm252956d1_ex99-1img035.jpg GRAPHIC 140625
41 GRAPHIC tm252956d1_ex99-1img036.jpg GRAPHIC 79727
42 GRAPHIC tm252956d1_ex99-1img037.jpg GRAPHIC 54486
43 GRAPHIC tm252956d1_ex99-1img038.jpg GRAPHIC 28354
44 GRAPHIC tm252956d1_ex99-1img039.jpg GRAPHIC 177954
45 GRAPHIC tm252956d1_ex99-1img040.jpg GRAPHIC 125883
46 GRAPHIC tm252956d1_ex99-1img041.jpg GRAPHIC 103408
  Complete submission text file 0001104659-25-002862.txt   8055987

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vyne-20250113.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vyne-20250113_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vyne-20250113_pre.xml EX-101.PRE 22377
57 EXTRACTED XBRL INSTANCE DOCUMENT tm252956d1_8k_htm.xml XML 3683
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 25524840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)